All Stories

  1. Assessment of skin yeast colonization and its predisposing factors among neonates admitted to the neonatal intensive care unit
  2. Reviewer Thank You List 2025
  3. Reviewer Thank You List 2025
  4. Design and immunological evaluation of a multi-epitope vaccine candidate against Toxoplasma gondii incorporating MIC13, GRA1, and SAG1 antigens in BALB/c mice
  5. Insights into Persian Gulf Beach Sand Mycobiomes: Promises and Challenges in Fungal Diversity
  6. Molecular epidemiology, diversity, and antifungal susceptibility profiles of clinical and environmental mucorales: a five-year multicenter study in Iran (2018–2023)
  7. Pathogenicity Evaluation on Fluconazole-Resistant Candida auris Clade V in Murine Model
  8. A fatal post-COVID-19 sino-orbital mucormycosis in an adult patient with diabetes mellitus: a case report and review of the literature
  9. Deciphering Fluconazole Resistance in Candida auris clade V: The Role of Efflux Pump Gene Expression and Ergosterol Pathway Mutations
  10. Characterization of COVID‐19‐Associated Candidemia Among Burn Patients
  11. A Novel Niosomal Gel for Topical Delivery of Miltefosine Against Trichophyton indotineae Dermatophytosis in Animal Model
  12. Acknowledging our reviewers
  13. Acknowledgement to Reviewers
  14. Genetic diversity and antibiotic resistance patterns of Escherichia coli isolates causing septicemia: A phylogenetic typing and PFGE analysis
  15. Reviewer acknowledgment 2024
  16. Prevalence of Fungal Infections in Pemphigus Patients: A Systematic Review and Meta‐Analysis
  17. Reviewer Acknowledgement 2024
  18. Reviewer Thank You List 2024
  19. An Unusual High Prevalence of Cryptococcus (Naganishia) diffluens Colonization in Neonates Hospitalized in a Referral Neonatal Intensive Care Unit
  20. Multi‐state evaluation of Candida infections in burn patients
  21. Metabolic Patterns of Fluconazole Resistant and Susceptible Candida auris Clade V and I
  22. High Prevalence of Terbinafine Resistance Among Trichophyton mentagrophytes/T. interdigitale Species Complex, a Cross-Sectional Study from 2021 to 2022 in Northern Parts of Iran
  23. Molecular Epidemiology and Antifungal Susceptibility Profile in Nakaseomyces glabrata Species Complex: A 5‐Year Countrywide Study
  24. Editorial Board
  25. Molecular typing of a collection of Iranian clinical Trichophyton tonsurans isolates based on the non‐transcribed spacer region of rDNA and antifungal susceptibility testing of the species
  26. Central nervous system Aspergillus quadrilineatus infection in a COVID‐19 patient, a case report and literature review
  27. Onychomycosis due to Fusarium species in different continents, literature review on diagnosis and treatment
  28. Investigating intestinal parasitic infections with emphasis on molecular identification of Strongyloides stercoralis and Trichostrongylus colubriformis in north of Iran
  29. Potential Inhibitory Effect of Miltefosine against Terbinafine-Resistant Trichophyton indotineae
  30. Antifungal activity of miltefosine against both azole-susceptible and -resistant Aspergillus strains
  31. Antifungal Resistance of Clinical Candida albicans Isolates in Iran: A Systematic Review and Meta-Analysis
  32. Acknowledgment to the Reviewers of Journal of Fungi in 2022
  33. Acknowledgment to the Reviewers of Diagnostics in 2022
  34. Acknowledgment to the Reviewers of Antibiotics in 2022
  35. Acknowledgment to the Reviewers of Life in 2022
  36. Enhancement of immune responses by vaccine potential of three antigens, including ROP18, MIC4, and SAG1 against acute toxoplasmosis in mice
  37. In vitro antifungal susceptibility profile of Iranian Fusarium isolates: Emphasising on the potent inhibitory effect of efinaconazole compared to other drugs
  38. 2022 OFID Reviewer Recognition List
  39. A new record of Scedosporium dehoogii isolated from paddy field soil in Iran: Phylogeny and antifungal susceptibility profiles
  40. First report of tinea corporis caused by Trichophyton quinckeanum in Iran and its antifungal susceptibility profile
  41. In Vitro Combination of Terbinafine with Ketoconazole Against Aspergillus Species with Terbinafine High MIC Values Isolated From Otomycosis
  42. Identification and multilocus genotyping of Toxoplasma gondii isolates from congenital infection in north of Iran
  43. P055 Antifungal resistance of clinical Candida albicans isolates in Iran: asystematic review and meta-analysis
  44. P285 Predominance of Trichophyton tonsurans causing tinea capitis: a 12-years retrospective study in north of Iran
  45. Post-antifungal effect of the combination of anidulafungin with amphotericin B and fluconazole against fluconazole-susceptible and -resistant Candida albicans
  46. Iranian National Survey on Tinea Capitis: Antifungal Susceptibility Profile, Epidemiological Characteristics, and Report of Two Strains with a Novel Mutation in SQLE Gene with Homology Modeling
  47. Genetic characterization of Toxoplasma gondii in meat-producing animals in Iran
  48. In vitro activity of 23 antifungal drugs against 54 clinical and environmental Aspergillus oryzae isolates
  49. Mass spectrometry in research laboratories and clinical diagnostic: a new era in medical mycology
  50. Otomycosis in the South of Iran with a High Prevalence of Tympanic Membrane Perforation: A Hospital-Based Study
  51. 2021 OFID Reviewer Recognition List
  52. Antifungal Properties of Zataria multiflora on Candida species: A Systematic Review
  53. Acknowledgment of Reviewers 2021
  54. Acknowledgment of Reviewers 2021
  55. In Vitro Antifungal Activity of Luliconazole, Efinaconazole, and Nine Comparators Against Aspergillus and Candida Strains Isolated from Otomycosis
  56. Molecular identification and antifungal susceptibility profiles of Candida dubliniensis and Candida africana isolated from vulvovaginal candidiasis: A single‐center experience in Iran
  57. Protective efficacy by a novel multi-epitope vaccine, including MIC3, ROP8, and SAG1, against acute Toxoplasma gondii infection in BALB/c mice
  58. Molecular Identification and Antifungal Susceptibility of Yeasts and Molds Isolated from Patients with Otomycosis
  59. Familial Cases of Trichophyton benhamiae Infection Transmitted from a Guinea Pig in Iran
  60. Toxoplasmosis among cancer patients undergoing chemotherapy: a population study based on the serological, molecular and epidemiological aspects
  61. In vitro activities of antifungal drugs against a large collection of Trichophyton tonsurans isolated from wrestlers
  62. Relationship between blood group and risk of infection and death in COVID-19: a live meta-analysis
  63. Candida africana vulvovaginitis: Prevalence and geographical distribution
  64. Relationship Between Blood Group and Risk of Infection and Death in COVID-19: a live Meta-Analysis
  65. Cryptococcus and cryptococcosis in Iran during 1969–2019: A systematic review and meta-analysis
  66. Antifungal Activity of a Novel Triazole, Efinaconazole and Nine Comparators against 354 Molecularly Identified Aspergillus Isolates
  67. The global serological prevalence of Toxoplasma gondii in felids during the last five decades (1967–2017): a systematic review and meta-analysis
  68. Cover Image
  69. In vitro activities of 15 antifungal drugs against a large collection of clinical isolates of Microsporum canis
  70. A systematic review of Toxoplasma gondii genotypes and feline: Geographical distribution trends
  71. Emerging Candida species isolated from renal transplant recipients: Species distribution and susceptibility profiles
  72. Molecular epidemiology of environmental Cryptococcus species isolates based on amplified fragment length polymorphism
  73. Human toxoplasmosis: a systematic review for genetic diversity of Toxoplasma gondii in clinical samples
  74. Pesticide behavior in paddy fields and development of azole-resistant Aspergillus fumigatus : Should we be concerned?
  75. Cerebral phaeohyphomycosis due to Rhinocladiella mackenziei in Persian Gulf region: A case and review
  76. <i>Toxoplasma gondii</i> Genotypes and Feline: Geographical Distribution Trends